Mirum Pharmaceuticals (08D) Q1 2026 Earnings Report
DE:08D Q1 2026 EPS Results
- Actual EPS
- -EUR 12.01
- Consensus EPS
- -EUR 0.33
- Beat/Miss
- Missed by -EUR 11.68
- One Year Ago EPS
- -EUR 0.27
DE:08D Q1 2026 Revenue Results
- Actual Revenue
- EUR 142.95M
- Expected Revenue
- EUR 132.51M
- Beat/Miss
- Beat by +EUR 10.44M
- YoY Revenue Growth
- +43.28%
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 05/06/2026
- Time
- After Close
- Conference Call
- Wednesday, May 6, 2026
DE:08D Upcoming Earnings
Mirum Pharmaceuticals's next earnings date is estimated for March 10, 2027, based on past reporting schedules.
Q1 2026 Earnings Call Audio
DE:08D Q1 2026 Earnings Call
0:00 / 0:00
Q1 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:08D Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 10, 2027 | 2026 (Q4) | ―- | -0.09 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | -0.44- | 0.04 | ― | |
| Aug 05, 2026 | 2026 (Q2) | -0.66-0.95 | -0.11 | -783.33% (-0.84) | |
| May 06, 2026 | 2026 (Q1) | -0.33-12.01 | -0.27 | -4376.67% (-11.74) | |
| Feb 25, 2026 | 2025 (Q4) | 0.05-0.09 | -0.44 | 79.59% (+0.35) | |
| Nov 04, 2025 | 2025 (Q3) | -0.130.04 | -0.27 | 116.67% (+0.31) | |
| Aug 06, 2025 | 2025 (Q2) | -0.29-0.11 | -0.46 | 76.92% (+0.36) | |
| May 07, 2025 | 2025 (Q1) | -0.30-0.27 | -0.48 | 44.44% (+0.21) | |
| Feb 26, 2025 | 2024 (Q4) | -0.23-0.44 | -0.56 | 22.22% (+0.13) | |
| Nov 12, 2024 | 2024 (Q3) | -0.40-0.27 | -0.51 | 47.37% (+0.24) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
